Shyam Metalics and Energy Limited (SMEL), a leading multi-metal conglomerate, announced its financial results for the quarter and half-year ended 30th September 2026, showcasing phenomenal growth across key metrics. The company reported a 33.4% year-on-year revenue growth to Rs. 5,960 crore, an impressive 52.6% year-on-year increase in operating EBITDA to Rs. 823 crore, and a massive 96.2% year-on-year surge in profit after tax to Rs. 511 crore in Q2 FY27.

Key Financial Highlights

SMEL’s robust performance is underscored by significant improvements in EBITDA margins, which expanded by 80 basis points year-on-year to 14.4%. The company’s return on equity (RoE) and return on capital employed (RoCE) also saw substantial growth, reflecting the company’s efficient capital utilization and operational efficiency.

Strategic Investments and Expansion

The company’s strategic investments and expansion plans are set to further bolster its growth trajectory. Notably, SMEL acquired a 51% controlling stake in Alom Solar Private Limited for the Phutamura Coal Block in Raigarh, Chhattisgarh, securing long-term coal supply for its captive power generation and steel manufacturing operations. Additionally, SMEL commissioned an 8.90-megawatt peak solar power plant at its Jamuria steel mill, advancing its commitment to cleaner energy.

Future Outlook

Looking ahead, SMEL plans to leverage its ongoing steel, stainless steel, and aluminium investments to drive stronger earnings. The company’s focus on higher-value products and prudent leverage management positions it well for sustained earnings growth. SMEL’s Chairman and Managing Director, Mr. Brij Bhushan Agarwal, expressed confidence in the company’s ability to fund its expansion program through internal accruals and maintain adequate liquidity.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Shyam Metalics and Energy Limited

Shyam Metalics and Energy Limited belongs to the Basic Materials › Steel sector. Here’s a quick read on where the business and the stock stand today.

Shyam gains 17.2% over three months and trades near its 52-week highs. The PEG reaches 3.78. The stock trades on brand and index weight, not on growth. Thin margins at 5.7% leave limited room for error — any demand softness or cost spike hits the bottom line hard. RSI hits 74, a level that signals the stock runs hot. Notably, buyers drove volume on 14 recent sessions — though at these levels, some profit-taking is normal. The stock rises 17.2% in three months on 13.6% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Shyam Metalics and Energy Limited.

Advanced Enzyme Technologies Limited (Advanced Enzymes; NSE: ADVENZYMES; BSE: 540025), a leading specialty biotech company, announced their unaudited financial results for the second quarter and half year ended September 2026. The company reported a revenue of ₹ 2,145 million in Q2 FY27, marking a 16% year-on-year growth compared to ₹ 1,845 million in Q2 FY26. Moreover, the profit after tax (PAT) grew by 14% to ₹ 512 million in Q2 FY27 from ₹ 447 million in Q2 FY26.

Financial Highlights

The consolidated EBITDA during Q2 FY27 stood at ₹ 721 million, a 20% increase from ₹ 601 million in the same quarter of the previous year. The EBITDA margin improved to 34% compared to 33% in Q2 FY26. The earnings per share (EPS) also rose to ₹ 4.33 in Q2 FY27 from ₹ 3.87 in Q2 FY26.

Segmental Performance

The Human Nutrition segment recorded a 6% year-on-year growth to ₹ 1,285 million. The Animal Nutrition segment saw a significant 37% growth to ₹ 265 million. The Bio-Processing segment delivered robust performance with a 43% year-on-year increase to ₹ 365 million. The Specialized Manufacturing segment contributed 25% growth to ₹ 231 million.

Therefore, the company’s diversified segments are driving consistent growth, positioning Advanced Enzyme Technologies Limited for a strong future.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Advanced drops 16.7% over three months and trades near its 52-week lows. Premium net margins of 22.1% demonstrate strong cost discipline and a wide competitive moat. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The stock sits at 9% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 11.3% and profits at 16.9% CAGR, with D/E of 0.00. Meanwhile, the stock dips 16.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Advanced Enzyme Technologies Limited.

Clean Science and Technology Limited (CLEAN) has reported consolidated revenue growth in Q2 FY27, driven by the expansion of new segments. The company’s progressive revenue growth is supported by its new business initiatives, although margins were moderated due to geopolitical headwinds. The company incurred total capex of approximately Rs. 150 crores during H1 FY2027 towards investments in its wholly-owned subsidiary, Clean Fino Chem Ltd. (CFCL).

Revenue and Profitability Overview

The consolidated revenue for Q2 FY27 stood at INR 233 crores, marking a 12% year-over-year increase from INR 207 crores in Q2 FY26. The company’s EBITDA stood at INR 82 crores, reflecting a slight decline of 5% compared to INR 87 crores in the same period last year. Profit after tax (PAT) for the quarter was INR 55 crores, a 25% decrease from INR 73 crores in Q2 FY26.

Segment Performance

The HALS segment, a significant contributor to the company’s revenue, grew twofold during H1 FY27 due to higher volumes. The company successfully de-risked product concentration, with the top four legacy products’ contribution declining from 85% in Q4 FY23 to 58% this quarter. The HALS segment now accounts for 22% of sales.

Forward-Looking Statement

Looking ahead, Clean Science and Technology Limited remains optimistic about its growth prospects, driven by continuous innovation and strategic investments in new segments. The company is poised to leverage its strong market position and technological advancements to achieve sustained revenue growth and profitability.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Clean Science and Technology Limited

Clean Science and Technology Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Clean posts a 5.3% three-month gain, but softens in the last few weeks. Margins at 23.7% are impressive but need to be sustained — any compression would be a red flag. Revenue contracts at 0.6% CAGR. That signals structural headwinds, not a short-term blip. The stock gives back 4.4% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 0.6% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Clean Science and Technology Limited.